Načítá se...
Fostamatinib in chronic immune thrombocytopenia: a profile of its use in the USA
Oral fostamatinib is an orally administered small molecule spleen tyrosine kinase (SYK) inhibitor approved for the treatment of adults with chronic immune thrombocytopenia (ITP) who have an inadequate response to a previous treatment. Fostamatinib has a unique mechanism of action, whereby its active...
Uloženo v:
| Vydáno v: | Drugs Ther Perspect |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer International Publishing
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6223701/ https://ncbi.nlm.nih.gov/pubmed/30459507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40267-018-0551-x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|